UK MHRA Med Dev Guidance: Ask for a Regulatory Advice Meeting & Regulation in Northern Ireland & Contacting

Understanding MHRA Guidance on Medical Device Regulations, Regulatory Advice Meetings, and Regulatory Support

Medical device manufacturers must navigate a wide range of regulatory requirements throughout the product lifecycle, from development and market access to post-market compliance and safety monitoring.

To support stakeholders, the Medicines and Healthcare products Regulatory Agency (MHRA) has published several guidance documents covering medical device regulatory requirements, regulatory advice services, and communication pathways.

The guidance documents Medical Devices: EU Regulations for MDR and IVDR, Medical Devices: Ask for a Regulatory Advice Meeting from the MHRA, and Contact MHRA collectively provide valuable information for manufacturers seeking to understand regulatory obligations, engage with regulators, and maintain ongoing compliance.

Regulation of medical devices in Northern Ireland

The guidance Medical Devices: EU Regulations for MDR and IVDR provides information regarding the application of the European Union Medical Devices Regulation (EU MDR 2017/745) and the In Vitro Diagnostic Medical Devices Regulation (EU IVDR 2017/746) for products placed on the Northern Ireland market.

These regulations were introduced to strengthen regulatory oversight, improve patient safety, increase transparency, and enhance traceability throughout the medical device lifecycle. The regulations establish more robust requirements for clinical evidence, performance evaluation, post-market surveillance, vigilance reporting, and quality management systems.

Manufacturers intending to place medical devices or in vitro diagnostic devices on the Northern Ireland market must ensure that their products comply with the applicable MDR or IVDR requirements. Depending on the classification of the device, manufacturers may be required to undergo conformity assessment procedures involving notified bodies and demonstrate compliance through appropriate technical documentation and supporting evidence.

Key Areas Governed by MDR and IVDR

Regulatory Area	Purpose
Clinical Evaluation	Demonstrates safety and performance
Performance Evaluation	Supports IVD effectiveness
Technical Documentation	Provides evidence of compliance
Conformity Assessment	Verifies regulatory compliance
Post-Market Surveillance	Monitors products after commercialization
Vigilance Reporting	Supports patient safety monitoring
CE Marking	Demonstrates conformity with applicable requirements

To help manufacturers address these challenges, the MHRA offers a regulatory advice service described in the guidance Medical Devices: Ask for a Regulatory Advice Meeting from the MHRA.

This service allows manufacturers and developers to engage directly with MHRA experts to discuss specific regulatory questions before making formal submissions or placing products on the market. Early engagement can help organizations better understand regulatory expectations and reduce uncertainty during development and commercialization.

Regulatory advice meetings may be particularly beneficial for:

• Novel medical technologies

• Software-based medical devices

• Artificial intelligence applications

• Innovative diagnostic products

• Devices involving complex classifications

• Products requiring clinical investigations

The guidance explains how applicants can request meetings, prepare supporting documentation, participate in discussions, and receive feedback from the agency.

Benefits of Regulatory Advice Meetings

Manufacturers may gain several advantages from early interaction with regulators, including:

• Clarification of regulatory pathways

• Improved development planning

• Better understanding of evidence requirements

• Early identification of potential regulatory challenges

• Enhanced submission quality

• Reduced risk of avoidable delays

Although regulatory advice does not constitute formal approval, it can provide valuable direction that supports more efficient product development and regulatory strategy planning.

Contacting the MHRA for Regulatory Support

Regulatory compliance often requires ongoing communication with regulatory authorities. Manufacturers may need assistance with registration activities, regulatory submissions, compliance questions, safety reporting, inspections, or post-market obligations.

The guidance Contact MHRA serves as a central resource for stakeholders seeking support from the agency.

The document provides information regarding appropriate contact channels for various MHRA functions and services. It helps manufacturers identify the correct departments responsible for handling specific regulatory enquiries and facilitates efficient communication with the agency.

Areas commonly supported through MHRA communication channels include:

• Medical device registrations

• Regulatory enquiries

• Compliance matters

• Safety reporting

• Device incidents

• Post-market surveillance activities

• Product defect reporting

• General regulatory support

Maintaining effective communication with the regulator is an important component of regulatory compliance and can help ensure that issues are addressed promptly and appropriately.

By understanding applicable regulatory requirements, engaging proactively with the MHRA, and utilizing established communication channels, manufacturers can strengthen regulatory compliance and improve their ability to successfully develop, register, and maintain medical devices throughout their lifecycle.

References

1. Medical Devices: Regulation of medical devices in Northern Ireland

2. Medical Devices: Ask for a Regulatory Advice Meeting from the MHRA

3. Contact MHRA